Lys181

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Methylation Site Page: > Lys181 - G-alpha(s) (human)

Site Information
CAQyFLDkIDVIkQA SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 1883454304

In vivo Characterization
Methods used to characterize site in vivo:	immunoprecipitation ( 1 ) , mass spectrometry ( 1 ) , modification-specific antibody ( 1 ) , mutation of modification site ( 1 ) , western blotting ( 1 )
Disease tissue studied:	liver cancer ( 1 )
Relevant cell line - cell type - tissue:	BNL CL.2 ( 1 ) , hepatocyte-liver ( 1 ) , HepG2 (hepatic) ( 1 )

Upstream Regulation
Treatments:	IL-6 ( 1 )

References
1	Zhou Y, et al. (2023) Malignant progression of liver cancer progenitors requires lysine acetyltransferase 7-acetylated and cytoplasm-translocated G protein GαS. Hepatology 77, 1106-1121 35344606 Curated Info

PhosphoSitePlus^® is a registered trademark of Cell Signaling Technology.
Use of PSP data is subject to a formal license agreement. Learn more